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CLINICAL RESEARCH STUDY
Association Between Alcohol Consumption and Both
Osteoporotic Fracture and Bone Density
Karina M. Berg, MD, MS,a,c Hillary V. Kunins, MD, MS, MPH,a,c Jeffrey L. Jackson, MD, MPH,d Shadi Nahvi, MD,a,c
Amina Chaudhry, MD, MPH,e Kenneth A. Harris, Jr, MD, PhD,a,c Rubina Malik, MD, MS,a Julia H. Arnsten, MD, MPHa,b,c
aDepartments of Medicine, bEpidemiology and Population Health, and cPsychiatry and Behavioral Sciences, Albert Einstein College of
Medicine and Montefiore Medical Center, Bronx, NY; d Uniformed Services University, Bethesda, Md; e Johns Hopkins University,
Baltimore, Md.
ABSTRACT
OBJECTIVE: Alcoholism is a risk factor for osteoporotic fractures and low bone density, but the effects of
moderate alcohol consumption on bone are unknown. We performed a systematic review and meta-
analysis to assess the associations between alcohol consumption and osteoporotic fractures, bone density
and bone density loss over time, bone response to estrogen replacement, and bone remodeling.
METHODS: MEDLINE, Current Contents, PsychINFO, and Cochrane Libraries were searched for studies
published before May 14, 2007. We assessed quality using the internal validity criteria of the US
Preventive Services Task Force.
RESULTS: We pooled effect sizes for 2 specific outcomes (hip fracture and bone density) and synthesized
data qualitatively for 4 outcomes (non-hip fracture, bone density loss over time, bone response to estrogen
replacement, and bone remodeling). Compared with abstainers, persons consuming from more than 0.5 to
1.0 drinks per day had lower hip fracture risk (relative risk  0.80 [95% confidence interval, 0.71-0.91]),
and persons consuming more than 2 drinks per day had higher risk (relative risk  1.39 [95% confidence
interval, 1.08-1.79]). A linear relationship existed between femoral neck bone density and alcohol consumption.
Because studies often combined moderate and heavier drinkers in a single category, we could not assess relative
associations between alcohol consumption and bone density in moderate compared with heavy drinkers.
CONCLUSION: Compared with abstainers and heavier drinkers, persons who consume 0.5 to 1.0 drink per
day have a lower risk of hip fracture. Although available evidence suggests a favorable effect of alcohol
consumption on bone density, a precise range of beneficial alcohol consumption cannot be determined.
© 2008 Elsevier Inc. All rights reserved. • The American Journal of Medicine (2008) 121, 406-418
KEYWORDS: Alcohol; Bone mineral density; Hip fracture; Meta-analysis; Osteoporosis
The prevalence of low bone density among men and women
aged more than 50 years has been estimated at greater than 44
million.1 In this population, 1 in 2 women and 1 in 4 men
develop osteoporotic fractures.2 In addition to unmodifiable
risk factors such as age and sex, bone density is influenced by
modifiable lifestyle factors, including alcohol consumption.
Chronic heavy alcohol consumption is widely considered
a risk factor for osteoporotic fractures and low bone dens-
ity.2 However, this relationship is based on small studies of
men3-7 and has not been established in women.8 In contrast,
several studies have reported that moderate alcohol use may
decrease fracture rates and increase bone density.9-18 In 2001,
a National Institutes of Health panel concluded that “alcohol-
ism” is a cause of osteoporosis but that “consumption of
alcoholic beverages” has an inconsistent effect on bone.19
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We performed a systematic review and meta-analysis to
assess the associations between alcohol consumption and
osteoporotic hip and non-hip fractures, bone density and
bone density loss over time, bone response to estrogen
replacement, and bone remodeling. Our secondary aim was
to examine whether the effect of
alcohol on these outcomes is mod-
ified by sex.
MATERIALS AND METHODS
Search Strategies
On May 14, 2007, we searched all
Ovid MEDLINE databases, the
Cochrane Central Register of
Controlled Trials, Current Con-
tents Connect, and PsychINFO.
We defined search terms for alco-
hol consumption and each out-
come (Appendix), and limited the
results to human subjects and En-
glish language. We then manually
searched references of included
studies and pertinent reviews.
Study Selection
Two reviewers independently assessed each citation using
predefined criteria. Included studies had experimental, co-
hort, or case-control designs; included adults both exposed
and not exposed to alcohol; and reported on at least 1
outcome. We excluded studies in which alcohol consump-
tion and bone density were measured once at the same point
in time to avoid invalid assumptions about temporal se-
quence. To examine osteoporotic fracture rate, we identified
studies of low-impact fractures of the hip, wrist, forearm, or
vertebra. To evaluate bone density, we sought prospective
studies in which bone density was assessed by central dual
energy x-ray absorptiometry and measured after alcohol
exposure. Studies examining bone density loss over time
required bone density measures at 2 points in time. To
examine the outcome of bone response to estrogen, we
identified studies reporting the effect of alcohol on osteo-
porotic fracture rates or bone density among postmeno-
pausal women taking estrogen replacement therapy. For the
final outcome, bone remodeling, we included studies exam-
ining markers of bone formation and resorption (Appendix).
Abstract ratings between reviewers had 92% agreement
(0.73). Disagreements were resolved by discussion.
Assessment of Study Quality
We assessed study quality using the internal validity criteria
of the US Preventive Services Task Force,20 assigning a
rating of “good” when all criteria were met, “fair” when 1
or more criterion was partially met and the study contained
no fatal flaws, and “poor” if 1 or more criterion was not met
and a fatal flaw invalidated the results. Studies of poor
quality were excluded.
For our systematic review, studies were rated “good” if
alcohol consumption was reported as a rate (eg, “drinks per
day”) and reflected data from more than a single survey item
(ie, from separate questions about
consumption of beer, wine, or
spirits). Studies that used a single
survey item, or did not sufficiently
explain their measures, were rated
“fair.” Studies that used imprecise
definitions of alcohol consump-
tion (eg, “ever,” “daily,” or “yes”)
were rated “poor.” In addition, we
rated studies on the timing of their
measurement of alcohol consump-
tion. Prospective studies were
rated “good” if alcohol consump-
tion was measured at multiple
time points and “fair” if alcohol
consumption was measured at
baseline only.
Prospective studies were rated
“good” if fractures were ascer-
tained by more than 1 source of
information (eg, self-report veri-
fied by hospital records or a sample of specific International
Classification of Diseases codes validated by chart review)
and “fair” if only 1 information source was used. Case-
control studies were rated “good” if cases were established
using hospital records and “fair” if they were established by
other means.
For all studies, we developed a predefined set of potential
confounders that included age, body mass index, smoking,
dietary calcium, physical activity, and estrogen exposure.
“Good” studies adjusted for all potential confounders, “fair”
studies adjusted for some confounders, and “poor” studies
adjusted for age only. Differences were discussed until
agreement was reached. Quality ratings between reviewers
had 85% agreement (0.67).
Data Extraction
The first author (KMB) and 1 other author met to extract
quantitative data on the association between alcohol con-
sumption and the outcome, and adjustment for potential
confounders. For example, data extracted may include the
odds of hip fracture among those who consumed more than
0.4 drinks per day compared with abstainers (odds ra-
tio0.69; 95% confidence interval [CI], 0.53-0.90), after
adjusting for age, body mass index, smoking, and estrogen
therapy.21 One investigator was contacted by the first author
to request numeric data that corresponded to a figure in the
original study.22 Because studies reported alcohol consump-
tion using numerous units of measurement, we converted
alcohol consumption into drinks per day by estimating that
each standard drink is equivalent to 14 g or 0.6 fluid oz of
CLINICAL SIGNIFICANCE
● Compared with abstinence, consuming
1 drink or less per day is associated with
a lower risk of hip fracture, whereas
consuming more than 2 drinks per day is
associated with higher hip fracture risk.
● Greater alcohol consumption (up to 2
drinks per day) is linearly associated
with higher bone density.
● Available literature is insufficient to de-
termine the precise range of alcohol
consumption that would maximize bone
density and minimize hip fracture risk.
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pure alcohol,23 that there are 29 kJ/g of alcohol,24 and that
1 unit of alcohol equals 8 g of pure alcohol.25
Data Synthesis
For pooled estimates of the effect of alcohol consumption
on hip fracture incidence, we extracted relative risk (RR)
data, created strata of alcohol use, and performed a dose-
response analysis using mean drinks per day when studies
reported ranges of alcohol consumption. For the few studies
that reported multiple categories of alcohol consumption
within 1 defined strata, we “pooled first” using inverse
variance weights. Given the rarity of events, RRs and odds
ratios for hip fractures were considered equivalent. We
combined fracture data by log transforming reported effects
in each stratum and then pooled data with the random
effects models.26 Sex-stratification of the analysis of alcohol
consumption and hip fracture was not possible because only
1 study reported results by sex.
For bone density, we pooled data using a dose-response
regression model with adjustment for clustering within stud-
ies using inverse variance as analytic weights.27 When nec-
essary, we imputed variance using the method of Follman et
al.28 For each outcome, when no upper limit was given for
the highest category of alcohol consumption, we multiplied
the reported limit by 1.5, a method used in a similar meta-
analysis.29 We were unable to perform a meta-analysis of
bone density loss over time because of the disparate out-
comes reported (eg, beta-coefficient for the effect of alcohol
on bone density loss, annual rate of bone density loss, or
percentage of bone density loss). The results were not sig-
nificantly different for men and women for any outcome
except bone density loss over time.
Heterogeneity was assessed using the Q and I2 statistics.
Publication bias was assessed using the method of Egger et
al.30 All meta-analyses were performed using STATA
(STATA 9.2, College Station, Tex).
RESULTS
Overview of the Evidence Base
The results of our search strategy are illustrated in Figure 1.
Most studies were conducted in white, European, or Amer-
ican adults aged more than 50 years. The results were
commonly adjusted for age, body mass index, and smoking.
However, few studies adjusted for dietary calcium, physical
activity, or estrogen exposure.
Alcohol Consumption and Hip Fracture Risk
Eight of 13 studies that examined the association between
alcohol consumption and risk of hip fracture were prospec-
tive cohort studies,33-40 and 5 were case-control stud-
ies21,31,32,41,42 (Table 1). The case-control studies compared
hospitalized cases with community controls,21,32,41 hospi-
talized controls,42 or both.31 Cases and controls were
matched on age, sex, race or ethnicity, and residential
area,31,32 or geographic location only.21,41,42
Meta-analysis of the effect of alcohol consumption on
hip fracture risk revealed a J-shaped relationship, which is
illustrated in Figure 2. Compared with abstainers, we found
a lower risk of hip fracture among persons consuming up to
0.5 drinks per day (RR0.84 [95% CI, 0.70-1.01] Q091,
I20.00, publication bias P .39) and persons consuming
from more than 0.5 to 1 drink per day (RR0.80 [95% CI,
0.71-0.91] Q12.66, I20.21, publication bias P .43).
Those consuming from more than 1 to 2 drinks per day did
Figure 1 Study selection process. Studies may be excluded for multiple reasons.
408 The American Journal of Medicine, Vol 121, No 5, May 2008
not differ from abstainers (RR0.91 [95% CI, 0.76-1.09]
Q11.33, I20.24, publication bias P .72), and persons
consuming more than 2 drinks per day had a higher risk of
hip fracture (RR1.39 [95% CI, 1.08-1.79] Q6.73,
I20.24, publication bias P .38).
Alcohol Consumption and Fracture of the
Forearm, Wrist, or Vertebrae
Of the 3 cohort studies that examined the effect of alcohol
consumption on fracture of the forearm or wrist, 2 found no
significant association40,43 and 1 found that women consum-
ing 1.8 drinks or more per day had a higher risk of wrist
fracture compared with abstainers (RR 1.38 [95% CI, 1.09-
1.74]).39 Two studies examined the relationship between
alcohol consumption and risk of vertebral fracture; 1 found
no significant association,40 and 1 found increased odds of
fracture among men who consumed more than 0.3 drinks
per day compared with abstainers (adjusted odds ratio 4.61
[1.19-17.90]).44
Alcohol Consumption and Bone Density
Four cohort studies assessed the association between alco-
hol consumption and bone density (Table 2).12,13,16,33 Over-
all, there was a linear relationship between femoral neck
bone density and alcohol consumption (Figure 3). Each
drink per day was associated with an increase in femoral
neck bone density of 0.045g/cm2 (95% CI, 0.008-0.082
g/cm2, P .01). A significant linear relationship also was
found at the vertebral spine (data not shown).
Alcohol Consumption and Bone Density Loss
Over Time
Four prospective cohort studies22,46-48 and 1 nested case-
control study45 examined the association between alcohol
consumption and bone density loss over time (Table 3).44-48
Two of the 3 studies that reported sex-stratified results
found that the pattern of association between alcohol con-
sumption and bone density loss was different in men and
women.46,47
Bone Density Loss Over Time in Women. Four of the 5
studies that examined alcohol consumption and bone den-
sity loss over time in women found that women with greater
alcohol consumption had lower bone density loss.21,45-48 Of
the 5 studies, 2 studies measured alcohol consumption con-
tinuously and found a significant inverse linear association
between alcohol consumption and bone density loss.45,46
Two other studies measured alcohol consumption categor-
ically and found the lowest bone density loss among women
with the greatest alcohol consumption (approximately 1-2
drinks per day).22,47 The final study found a U-shaped
relationship between alcohol consumption and bone density
loss, with the lowest bone density loss among women con-
suming 0.2 to 1.7 drinks per day and higher bone density
loss among both abstainers and women consuming more
than 1.7 drinks per day.48
Bone Density Loss Over Time in Men. Of the 3 studies that
assessed alcohol consumption and bone density loss over time
in men, 2 reported U-shaped relationships.47,48 The lowest
bone density loss was among men in the middle drinking
categories (between 0.7 and either 1.4 or 1.7 drinks per day),
and higher bone density loss was among men with either little
or no alcohol consumption and men with the greatest alcohol
consumption (at least 1.4 or 1.7 drinks per day). The third
study found no linear relationship between continuous alcohol
consumption and bone density loss in men.46
Alcohol Consumption and Bone Response to
Estrogen Replacement
Two studies assessed the effect of alcohol consumption on
bone response to estrogen therapy. One prospective cohort
study found that estrogen therapy was independently asso-
ciated with a 74% lower risk of hip fracture (RR 0.36 [95%
CI, 0.14-0.90]) among women who consumed 1 drink or
more per day, compared with abstainers.49 The other was a
nested case-control study that defined cases (“good” re-
sponders) as women who gained more bone density during
5 years of follow-up than the upper 95th percentile of an
untreated group.45 After adjustment for multiple potential
confounders, alcohol intake was independently associated
with being a “good” responder to estrogen therapy.
Alcohol Consumption and Markers of Bone
Remodeling
Markers of Bone Formation. Osteocalcin, a vitamin K-
dependent protein synthesized by osteoblasts, is widely
used as a clinical marker of bone formation. In 6 experi-
mental studies of heavy drinkers (7-16 drinks per day), the
subjects served as their own controls. Osteocalcin levels
were measured before and after periods of abstinence rang-
ing from 7 days to 2 years.8,50-54 All studies found that
osteocalcin increased significantly after abstinence.
Two additional experimental studies found consistent
results after administering alcohol to healthy male
adults.55,56 The doses of alcohol varied from 1.8 drinks
given over 45 minutes55 to 4 drinks administered daily for
3 weeks.56 Both studies found a significant decrease in
osteocalcin levels during alcohol administration.
Three of the abstinence studies also examined changes in
carboxy-terminal propeptide of type I procollagen,8,52,54 a
protein representing synthesis of type-1 collagen. All found
a significant increase in carboxy-terminal propeptide of type
I procollagen during abstinence.
Markers of Bone Resorption. Hydroxyproline, a modified
amino acid that is released during the breakdown of colla-
gen, was measured in 3 studies of heavy drinkers. During
abstinence from alcohol, 1 study found a significant increase
in urinary hydroxyproline,54 and 2 studies found no signif-
icant change.8,53
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Table 1 Studies of the Association between Alcohol Consumption and Risk of Hip Fracture
Study, year Study Design Sample Characteristics
Study
Quality
Duration of Follow-
up
Felson, 1988 (34) Framingham Study cohort 5209 adults, aged 31–95 yrs fair* 117,224 person-years
Hoidrup (men), 1999 (35) Combined data from
three cohort studies
17,868 men, aged 20–93 yrs fair* 434,324 person-years
Hoidrup (women), 1999 (35) Combined data from
three cohort studies
13,917 women, aged 20–93 yrs fair* 434,324 person-years
Kanis, 2004 (36) Combined data from
three cohort studies
16,971 adults, aged 25–103 yrs fair*†‡ 75,433 person-years
Holbrook, 1988 (37) Rancho Bernando cohort 957 adults, aged 50–79 yrs fair*†‡ 14 years
Hemenway, 1994
AmJPubHealth (38)
Health Professionals
Follow-Up Study
cohort
49,895 men, aged 40–75 yrs fair*†‡ 270,000 person-years
Hernandez-Avila, 1991 (39) Nurses Health Study
cohort
84,484 women, aged 29–74 yrs fair*† 482,347 person-years
Hansen, 2000 (40) Iowa Women’s Health
Study cohort
34,703 women, aged 55–69 yrs fair†§ 187,035 person-years
Mukamal, 2007 (33) Cardiovascular Health
Study cohort
5865 adults, aged 65 yrs fair* 70,380 person-years
Cumming, 1994 (41) Case-control 416 adults, aged 65–100 yrs
(209 cases, 207 controls)
fair* NA
Baron, 2001 (21) Case-control 4589 postmenopausal women
(1,327 cases, 3,262
controls)
fair* NA
Grisso, 1994 (31) Case-control 543 black women (144 cases,
399 controls)
fair*‡ NA
La Vecchia, 1991 (42) Case-control 1658 women, aged 29–74 yrs
(209 cases, 1449 controls)
fair* NA
Suzuki, 1997 (32) Case-control 747 adults, aged 65–89 yrs
(249 cases, 498 controls)
fair*‡ NA
*Incomplete adjustment for potential confounders (age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure in women).
†alcohol consumption measured at baseline only (prospective studies).
‡1 survey item to measure alcohol consumption or poor explanation of measurement methods
§fractures ascertained from a single source (prospective studies); II cases not established using hospital records (case-control studies); NA indicates
not applicable; BMI indicates body mass index; CVA indicates cerebrovascular accident; DM indicates diabetes mellitus; “Former drinkers” defined as
participants who reported abstinence at baseline but at a follow-up visit responded “yes” to either a “change in pattern of drinking in the past 5 years”
or “ever regularly consumed  drinks daily.
¶Gaps in categories due to conversion from drinks per week to drinks per day.
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Table 1 Continued
Timing of Measurement
of Alcohol Use Events Potential Confounders Adjusted for in Analysis
Unit of Analysis of
Alcohol
Magnitude of Association
(95% CI)
Baseline and years 4,
10, 20, 22, 24, 26,
and 30
217 Age, sex, weight, smoking per 7 oz/wk Odds Ratio: 1.28 (1.05–
1.56)
Baseline and between
1 and 3 follow up
interviews
307 Age, BMI, smoking, physical activity, original
cohort, education, cohort of origin
0.1 drinks/day
0.1–0.9 drinks/day
1–1.9 drinks/day
2–3.9 drinks/day
4–5.9 drinks/day
6–9.9 drinks/day
10 drinks/day
Relative Risk: 1.00
0.89 (0.58-1.38)
0.84 (0.54-1.30)
0.84 (0.54-1.32)
1.74 (1.06-2.89)
1.84 (1.00-3.41)
5.28 (2.60-10.70)
Baseline and between
1 and 3 follow up
interviews
500 Age, BMI, smoking, physical activity, original
cohort, education, cohort of origin
0.1 drinks/day
0.1–0.9 drinks/day
1–1.9 drinks/day
2–3.9 drinks/day
4 drinks/day
Relative Risk: 1.00
0.89 (0.71–1.12)
1.01 (0.77–1.33)
1.32 (0.92–1.87)
1.01 (0.37–2.75)
Unspecified 279 BMD 0.6 drinks/day
1.1 drinks/day)
1.7 drinks/day
2.3 drinks/day
Relative Risk: 1.00
1.70 (1.20–2.42
2.05 (1.35–3.11)
2.39 (1.39–4.09)
Baseline 33 Age, sex, BMI, smoking per 0.9 drinks/day Relative Risk: 1.00
Baseline 67 Age, BMI, smoking, height 0 drinks/day
0–1.1 drinks/day
1.1–2.1 drinks/day
2.1 drinks/day
Relative Risk: 1.00
1.06 (0.58–1.93)
0.95 (0.42–2.17)
0.91 (0.38–2.17)
Baseline 65 Age, BMI, menopausal status, estrogen therapy,
calcium use, caffeine exposure
0 drinks/day
0–0.4 drinks/day
0.4–1.1 drinks/day
1.1–1.8 drinks/day
1.8 drinks/day
Relative Risk: 1.00
0.94 (0.35–2.68)
1.99 (0.97–4.07)
1.15 (0.51–2.61)
2.33 (1.18–4.57)
Baseline 275 Age, BMI, smoking, physical activity, estrogen
therapy, calcium use, caffeine exposure,
calories, waist:hip ratio
0 drinks/day
0.3 drinks/day
0.3 drinks/day
Relative Risk: 1.00
0.92 (0.68–1.24)
0.79 (0.57–1.10)
Baseline and annually
for 9 or 10 years
412 Age, sex, smoking, weight, height, leisure time
physical activity, difficulty arising from a bed
or chair, estrogen therapy, thiazide type
diuretics, thyroid agents, race, diabetes,
hypertension, cardiovascular disease, visual
problems, arthritis, previous cancer, weight in
early teens, Mini-Mental Status Exam score
0 drinks/day¶
former drinkers
0.14 drinks/day
0.14–0.86 drinks/day
1–1.86 drinks/day
2 drinks/day
Hazard Ratio 1.00
0.84 (0.50–1.43)
0.77 (0.61–0.98)
0.83 (0.61–1.12)
0.82 (0.53–1.26)
1.20 (0.74–1.95)
NA NA Age, sex 0 drinks/day
1 drinks/day
1 drinks/day
Odds Ratio: 1.00
0.70 (0.50–1.20)
0.60 (0.30–1.30)
NA NA Age, BMI, smoking, estrogen therapy nondrinkers
drinkers
0.2 drinks/day
0.2–0.4 drinks/day
0.4 drinks/day
Odds Ratio: 1.00
0.70 (0.60–0.82)
0.72 (0.59–0.88)
0.70 (0.56–0.87)
0.69 (0.53–0.90)
NA NA Age, BMI, area of residence 0–0.1 drinks/day
0.1–0.9 drinks/day
1 drinks/day
Odds Ratio: 1.00
1.3 (0.6–2.9)
2.2 (0.9–5.7)
NA NA Age, BMI, smoking, estrogen therapy, education,
area of residence
0 drinks/day
2 drinks/day
2–3 drinks/day
3 drinks/day
Relative Risk: 1.00
0.7 (0.5–1.1)
1.2 (0.8–1.8)
1.0 (0.5–1.8)
NA NA BMI, physical activity, coffee and green tea, rural
residence, main work activity, sleep
disturbance, CVA hemiplegia, DM, milk, fish,
sun exposure, immobilization, difficulty
bathing independently, type of bed
0 drinks/day
1.9 drinks/day
1.9 drinks/day
Odds Ratio: 1.00
0.51 (0.29–0.89)
0.77 (0.33–1.79)
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Figure 2 Association between alcohol consumption and hip fracture risk. Reference exposure
is zero drinks per day. Size of data marker represents sample size. Horizontal lines denote 95%
confidence intervals.
Table 2 Studies of the Association between Alcohol Consumption and Bone Mineral Density
Study, Year Sample Characteristics
Study
Quality
Duration of
Follow-up
Measurement of
Alcohol Consumption Outcome Measure
Mukamal, 2007 (33) 5865 adults, aged  65 yrs fair* 12 years Baseline and annually
for 9 or 10 years
femoral neck BMD
Holbrook et al. (Rancho
Bernando), 1993
(13)
267 women, mean age 60 yrs fair* 12 yrs Baseline and year 12 femoral neck BMD
Felson et al.
(Framingham Study),
1995 (12)
1,154 adults, aged 68–96 yrs
(data shown for women)
fair* 20 yrs Baseline and years 2,
4, 6, 8, 10, 12, 14,
and 16
femoral neck BMD
Feskanich et al.
(Nurses’ Health
Study), 1999 (16)
188 women, aged 50–74 fair* 14 yrs Baseline and years 4,
6, and 10
femoral neck BMD
Holbrook et al. (Rancho
Bernando), 1993
(13)
182 men, mean age 59 yrs fair* 12 yrs Baseline and year 12 femoral neck BMD
Felson et al.
(Framingham Study),
1995 (12)
1,154 adults, aged 68–96 yrs
(data shown for men)
fair* 20 yrs Baseline and years 2,
4, 6, 8, 10, 12, 14,
and 16
femoral neck BMD
*Incomplete adjustment for potential confounders (age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure in women); NS
indicates “not significant. BMD indicates bone mineral density; BMI indicates body mass index; “Former drinkers” defined as participants who reported abstinence
at baseline but at a follow-up visit responded “yes” to either a “change in pattern of drinking in the past 5 years” or “ever regularly consumed 5 drinks daily.
†Gaps in categories due to conversion from drinks per week to drinks per day.
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DISCUSSION
Our analysis demonstrates a J-shaped relationship between
alcohol consumption and hip fracture risk, with persons
consuming up to 1 drink per day having the lowest risk of
hip fracture. In contrast, most data on alcohol consumption
and bone density suggest a linear association between
greater alcohol consumption and both higher bone density
and lower bone density loss over time. Studies evaluating
hip fracture risk included subjects with greater alcohol con-
sumption than studies evaluating bone density, which may
explain why the association between alcohol consumption
and hip fracture was J-shaped rather than linear. Because
studies of alcohol consumption and bone density included
few heavier drinkers, current evidence is insufficient to
determine a precise amount of alcohol consumption that is
associated with higher bone density.
Compared with abstainers, moderate drinkers had lower
hip fracture risk and heavier drinkers had higher hip fracture
risk. However, important biases may have influenced these
results. It is likely that falls contributed to the observed
increase in hip fracture risk among heavier drinkers. Fur-
ther, most categories of nondrinkers included both lifetime
abstainers and former drinkers. If former drinkers stopped
for health reasons, this may partially explain the higher hip
fracture risk among nondrinkers.
In contrast with the J-shaped association between alcohol
consumption and hip fracture risk, pooled data suggest a
linear relationship between alcohol consumption and bone
density. These data were derived from studies mainly of
individuals consuming less than 2 drinks per day. Because
these studies may have been underpowered to demonstrate
changes in bone density at greater alcohol consumption
levels, the observed linear association may not fully de-
scribe this relationship. In addition, the increase in bone
density associated with each additional drink per day was
small in magnitude and of uncertain clinical significance.
The exact mechanism by which alcohol influences bone
density is not clear. Putative biological mechanisms for a
beneficial effect of alcohol on bone density include increases in
the concentration of serum estradiol57,58 and liver estrogen
receptors.59 However, as has been suggested regarding other
beneficial effects of moderate alcohol consumption, the ob-
served benefit may reflect confounding by unmeasured healthy
behaviors.60,61 An important limitation of the existing litera-
ture, and the reason most studies were rated “fair,” is that few
studies sufficiently adjusted for major potential confounders,
and none included markers of socioeconomic status. Although
our finding that alcohol consumption augments the benefits of
estrogen therapy is based on a small number of studies, it is
consistent with research suggesting that alcohol ingestion leads
to elevations in circulating estradiol levels in women taking
Table 2 Continued
Potential Confounders Adjusted for in Analysis
Statistical Measure
of Association
Unit of Analysis of
Alcohol
BMD
(g/cm2) p Value
Age, sex, smoking, weight, height, leisure time physical activity, difficulty
arising from a bed or chair, estrogen therapy, thiazide type diuretics,
thyroid agents, race, diabetes, hypertension, cardiovascular disease,
visual problems, arthritis, previous cancer, weight in early teens, Mini-
Mental Status Exam score
F-tests 0 drinks/day†
former drinkers
0.14 drinks/day
0.14–0.86 drinks/day
1–1.86 drinks/day
 2 drinks/day
0.69
0.72
0.69
0.70
0.73
0.74
0.001
Age, smoking, BMI, exercise and estrogen therapy 2 0 drinks/day
0.5 drinks/day
0.5–1.2 drinks/day
1.2 drinks/day
0.64
0.63
0.62
0.64
NS
Age, smoking, weight, height, age at menopause, durat ion of estrogen
use
2 0.2 drinks/day†
0.2–0.4 drinks/day
0.7–1.4 drinks/day
1.7 drinks/day
0.71
0.70
0.71
0.74
NS
Age, smoking, BMI, estrogen therapy, age at menopause 2 0.3 drinks/day
0.3–0.8 drinks/day
0.8 drinks/day
0.65
0.67
0.67
NS
Age, smoking, BMI, exercise 2 0 drinks/day
0.9 drinks/day
0.9–1.8 drinks/day
1.8 drinks/day
0.68
0.72
0.78
0.75
0.01
for
trend
Age, smoking, weight, height 2 0.2 drinks/day
0.2–0.4 drinks/day
0.7–1.4 drinks/day
1.7–2.9 drinks/day
3 drinks/day
0.86
0.86
0.88
0.85
0.88
NS
413Berg et al Alcohol Consumption and Osteoporotic Fracture
Figure 3 Association between alcohol consumption and adjusted femoral neck bone mineral
density. Adjustment for confounders is variable. Study adjusting for the fewest covariates controlled
for age, smoking, weight, and height. Study adjusting for the most covariates also controlled for
leisure time physical activity, difficulty arising from a bed or chair, estrogen therapy, thiazide-type
diuretics, thyroid agents, race, diabetes, hypertension, cardiovascular disease, visual problems, arthri-
tis, previous cancer, weight in early teens, and Mini-Mental Status Exam score.
Table 3 Studies of the Association between Alcohol Consumption and Bone Mineral Density Loss Over Time
Study, Year Sample Characteristics
Study
Quality
Duration of
Follow-up
Measurement of Alcohol
Consumption Outcome (Unit)
BMD loss at the femoral neck among women
Dennison et al. 1999 (46) 143 women, aged 60–75 yrs fair*‡ 4 yrs Baseline and year 4 Annual BMD loss at the
femoral neck
Rejnmark et al. (Danish Osteoporosis
Prevention Study), 2004 (45)
932 women, mean age 49 yrs fair*†‡ 5 yrs Baseline BMD loss at the
femoral neck (g/
cm2)
Macdonald et al. 2004 (22) 891 women, aged 45–55 yrs fair* 5–7 yrs Baseline and year 5 Annual BMD loss at the
femoral neck (%/yr)
Burger et al. (Rotterdam Study), 1998 (47) 2452 women, mean age 67 yrs fair*†‡ median 1.9 yrs Baseline Annual BMD loss at the
femoral neck (g/
cm2/yr)
Hannan et al. (Framingham Osteoporosis
Study), 2000 (48)
486 women, aged 67–90 yrs fair*†‡ 4 yrs Baseline Percent BMD loss at
the femoral neck
(%)
BMD loss at the femoral neck among men
Burger et al. (Rotterdam Study), 1998 (47) 1856 men, mean age 67 yrs fair†‡ median 1.9 yrs Baseline Annual BMD loss at the
femoral neck (g/
cm2/yr)
Hannan et al. (Framingham Osteoporosis
Study), 2000 (48)
278 men, aged 67–90 yrs fair*†‡ 4 yrs Baseline Percent BMD loss at
the femoral neck
(%)
Dennison et al. 1999 (46) 173 men, aged 60–75 yrs fair‡ 4 yrs Baseline and year 4 BMD loss at the
femoral neck (%/yr)
*Incomplete adjustment for potential confounders (age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure in women).
†alcohol consumption measured at baseline only.
‡1 survey item to measure alcohol consumption or poor explanation of measurement methods. BMD indicated bone mineral density; BMI indicates body
mass index; NS indicates not significant; NR indicates not reported.
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estrogen replacement therapy.62-64 Because of this association,
studies that did not control for estrogen exposure may be
particularly vulnerable to bias.
Most studies of bone density loss in women demon-
strated an inverse linear relationship between alcohol con-
sumption and bone density loss over time, whereas most
studies in men reported a J-shaped relationship. Although
sex differences in the effect of alcohol consumption on bone
density have been suggested,65 observed differences might
be explained by differences in alcohol exposure. Studies of
bone density loss over time frequently combined moderate
and heavy drinkers in a single category, making the greatest
drinking category heterogeneous. For example, if the pop-
ulation of women categorized as consuming more than 1.4
drinks per day consumed less alcohol than men in the same
drinking category, data from men and women would sug-
gest different patterns of association between alcohol con-
sumption and bone density due partly to misclassification.
Further research is needed to characterize sex differences in
the effect of alcohol on bone density loss over time.
Data from experimental studies indicate that osteocalcin
increases after abstinence and decreases after alcohol ad-
ministration. These results suggest a reversible suppression
of bone formation when administered rapidly or in large
doses, and are consistent with prior research.66,67 The effect
of long-term alcohol consumption on bone remodeling
likely involves a complex uncoupling of formation and
resorption.68 Heavy alcohol consumption may have a direct
acute negative effect on osteoblasts, but positive effects of
alcohol on bone density may be due to indirect long-term
hormonal effects.69 The precise effects of moderate alcohol
consumption on bone metabolism are still unknown.
A key limitation of many original studies in this review
was the method and timing of alcohol consumption mea-
surement, a weakness that has been noted by other reviews
and meta-analyses of alcohol consumption.29,70,71 Studies
that measured alcohol consumption only at baseline are
vulnerable to misclassification if exposure to alcohol
changed before the outcome was measured. In addition,
collecting data on alcohol consumption by self-report using
simple surveys may lead to underreporting, particularly
among heavy drinkers.72,73 Despite this potential reporting
bias, the rank order of alcohol consumption reported by
individual studies is unlikely to be affected.
Because most included studies were observational, these
results must be interpreted with caution. Although many
benefits, including decreased mortality,74 have been attrib-
uted to moderate alcohol consumption, the appropriateness
Table 3 Continued
Potential Confounders Adjusted for in
Analysis
Statistical Measure
of Association
Unit of Analysis of
Alcohol
BMD
Loss
Magnitude of
Association p Value
Age, smoking, BMI, change in BMI, activity,
calcium intake, osteoarthritis grade
Beta-coefficient per 0.1 drinks/day NA (0.07) 0.007
Age, smoking, weight, waist to hip ratio,
time since menopause, est rogen therapy,
total energy, calcium, vitamin D intake,
metabolic markers of metabolism
Beta-coefficient per gram of alcohol/day NA (0.048) p  0.001
Age, smoking, height, weight, weight
change, BMD, activity, activity change,
menopausal status, estrogen therapy,
socioeconomic status, consuming a
weight-reducing diet, osteoarthritis
Beta-coefficient per quartile (medians)
0 drinks/day
0.2 drinks/day
0.5 drinks/day
1.0 drinks/day
NA (0.0893) 0.002
Age, smoking, BMI, calcium and energy
intake, lower limb disability
Beta-coefficient 0 drinks/d
0–0.7 drinks/day
0.7–1.4 drinks/day
1.4 drinks/day
0.0056
0.0042
0.0051
0.0027
NR NS
Age, smoking, weight, weight change,
height, estrogen therapy
Least squares mean 0–0.2 drinks/day
0.2–0.7 drinks/day
0.7–1.7 drinks/day
1.7 drinks/day
2.39
2.05
2.28
3.09
NR NS
Age, smoking, BMI, calcium and energy
intake, lower limb disability
Beta-coefficient 0 drinks/day
0–0.7 drinks/day
0.7–1.4 drinks/day
1.4 drinks/day
0.0057
0.0025
0.0012
0.0048
NR NS
Age, smoking, weight, weight change, height Least squares mean 0–0.2 drinks/day
0.2–0.7 drinks/day
0.7–1.7 drinks/day
1.7 drinks/day
2.68
2.66
2.57
3.27
NR NS
Age, smoking, BMI, change in BMI, activity,
calcium intake, osteoarthritis grade
Beta-coefficient per 0 .1 drinks/day NA NR NS
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of using nondrinkers as a reference group has been ques-
tioned.75,76 To expand our understanding of the effects of
alcohol on bone density, rigorous prospective studies are
needed that carefully measure potential confounders. Be-
cause bone density reflects the cumulative effects of numer-
ous factors on bone metabolism over long periods of time,
future studies should adjust for baseline bone density.
CONCLUSIONS
Current best evidence on the effect of alcohol on bone density
suggests that compared with abstinence, consumption of up to
1 drink per day is associated with a decreased risk of osteo-
porotic hip fracture. Further, most evidence supports a benefi-
cial effect of moderate alcohol consumption on bone density.
However, evidence is insufficient to determine relative associ-
ations between alcohol consumption and bone density in mod-
erate compared with heavy drinkers.
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APPENDIX
Medical Subject Headings and Text Words Used in Literature Search
Concept MeSH Terms Text Words
Alcohol Consumption Alcohol-related disorders
Alcoholism
Alcoholic beverages
Alcohol drinking
Alcohol, alcoholic, alcoholism, beer, wine, liquor
Bone Mineral Density Osteoporosis
Postmenopausal osteoporosis
Bone density Metabolic bone diseases
Pathologic bone demineralization
Osteoporosis, osteopenia, bone mineral density, BMD, bone resorption
Osteoporotic Fractures Fractures
Spontaneous fractures
Hip fracture
Spinal fractures
Wrist injuries
Compression fracture, fragility fracture, atraumatic fracture
Metabolism Bone resorption Telopeptide, n-telopeptide, c-telopeptide, osteocalcin, bone-Gla
protein, BGP, bone and alkaline phosphatase, deoxypyridinoline,
hydroxyproline, tartrate-resistant acid phosphatase, TRACP, bone and
sialoprotein, hydroxylysine
BMD, Bone mineral density; BGP, beta-glycerophosphatase; TRACP, tartrate-resistant acid phosphatase.
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